MUC2 and cancer: Except that, the probability of some differential expression genes, such as MUC2, CLCA1, REG4, and FGF3 can be used as prognostic biomarkers in NSCLC is worth exploring because they have been reported as a biomarkers in other cancers as well (52–55).